Yu Dan Tong Formula inhibits NLRP3 inflammasome activation by suppressing Ca²⁺ influx in treating cholestatic liver disease

Key Points

• Inhibition of nlrp3 inflammasome activation was observed, indicating a potential treatment effect.
• The study revealed that suppressing calcium influx significantly impacts disease mechanisms.
• Analysis focused on the role of calcium in cholestatic liver disease, highlighting critical pathways.
• Further research may validate these findings in broader populations to strengthen implications.